Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Neoplasms × avelumab × Clear all

Phase

Phase 1/2 3 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 11 Carcinoma, Transitional Cell 11 Colorectal Neoplasms 9 Carcinoma, Merkel Cell 8 Breast Neoplasms 7 Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Small Cell Lung Carcinoma 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Neuroendocrine Tumors 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Turcot syndrome 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Penile Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Melanoma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Neuroendocrine 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thymoma 1

Interventions

Docetaxel 122 Prednisone 105 Abiraterone Acetate 79 Leuprolide 76 enzalutamide 74 Radiotherapy 49 Goserelin 48 bicalutamide 45 Magnetic Resonance Spectroscopy 45 Androgen Antagonists 42 apalutamide 39 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 39 Radiosurgery 30 abiraterone 29 cabazitaxel 28 Gonadotropin-Releasing Hormone 26 Specimen Handling 25 Carboplatin 25 gallium 68 PSMA-11 23 darolutamide 23 Estramustine 22 Metformin 21 luprolide acetate gel depot 20 relugolix 19 Triptorelin Pamoate 19 Radiation 18 Pluvicto 18 Brachytherapy 18 sipuleucel-T 16 prednylidene 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03179410 2021-03-05

PICK-NEPC

Duke University

Phase 2 Completed

15 enrolled 12 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡